Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Carelon Research

Clinical trials sponsored by Carelon Research, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Shunt vs stent: which is better for tiny hearts? Results expected Sep 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 3

Cancer drug tested against deadly infant heart disease

Disease control Not yet recruiting

Researchers are testing whether trametinib, an FDA-approved cancer drug, can help infants with RASopathies who have a severe, life-threatening heart condition called hypertrophic cardiomyopathy. The trial enrolls about 25 babies with a confirmed genetic diagnosis. Participants re…

Phase 3 • Sponsor: Carelon Research • Aim: Disease control

Last updated Sep 16, 2026 00:00 UTC